Alcohol Use Disorders in Europe & Central Asia
Country-level alcohol use disorders mortality data for Europe & Central Asia. Age-standardized death rates per 100,000 population from the IHME Global Burden of Disease Study.
| # | Country | Rate |
|---|
This page presents alcohol use disorders mortality data for countries in Europe & Central Asia, using age-standardized death rates per 100,000 population from the Institute for Health Metrics and Evaluation (IHME). Regional analysis reveals significant variation in disease burden between countries, reflecting differences in healthcare infrastructure, socioeconomic conditions, environmental risk factors, and public health policy implementation across Europe & Central Asia.
Alcohol use disorders encompass a spectrum from harmful drinking to severe dependence, characterised by impaired control over consumption, tolerance, withdrawal symptoms, and continued use despite adverse consequences. Alcohol kills through multiple pathways: acute intoxication causes fatal poisoning, aspiration, and injury; chronic heavy use drives alcoholic liver disease (steatosis, hepatitis, cirrhosis), alcoholic cardiomyopathy, pancreatitis, and several cancers including oropharyngeal, oesophageal, hepatocellular, and colorectal malignancies. Globally, alcohol is attributable to approximately 3 million deaths per year — roughly 5.3% of all deaths — making it one of the leading preventable risk factors for premature mortality. The burden falls disproportionately on men, who account for over 75% of alcohol-attributable deaths. Eastern Europe and parts of sub-Saharan Africa experience the highest per-capita alcohol mortality, with Russia and surrounding nations historically exhibiting extreme rates of alcohol-related liver disease and poisoning. Economic costs extend far beyond health, encompassing lost productivity, criminal justice, and family disruption. Europe and Central Asia benefit from relatively strong health systems and high physician density, but face ageing populations, rising non-communicable disease burdens, and persistent East-West health outcome gradients. In Europe & Central Asia, alcohol use disorders mortality is near global averages, though the region exhibits a marked gradient between Western European countries with low rates and Central Asian nations facing higher burdens.
The WHO's SAFER initiative outlines five high-impact strategies: strengthening restrictions on alcohol availability, advancing and enforcing drink-driving countermeasures, facilitating access to screening and brief interventions, enforcing bans on alcohol advertising and promotion, and raising prices through taxation. Minimum unit pricing, implemented in Scotland and parts of Canada, has demonstrated reductions in alcohol-related hospitalisations and deaths. Treatment for alcohol use disorder includes pharmacotherapy (naltrexone, acamprosate, disulfiram) alongside psychosocial interventions such as cognitive behavioural therapy and mutual support groups.
The mortality estimates presented on this page are derived from the Global Burden of Disease (GBD) study, produced by the Institute for Health Metrics and Evaluation (IHME). The GBD synthesizes data from vital registration systems, verbal autopsies, cancer registries, and surveillance networks across more than 200 countries and territories. Death rates are expressed per 100,000 population and are age-standardized, which adjusts for differences in age structure between populations so that comparisons across countries and over time reflect genuine differences in mortality risk rather than demographic composition.
The dataset typically covers the period from 1990 to 2023, although availability varies by country and cause. When interpreting the figures for alcohol use disorders in Europe & Central Asia, note that higher age-standardized rates indicate a greater mortality burden independent of whether a country's population is older or younger. Trends over time reveal whether public health interventions, economic development, and health system improvements have reduced or increased the toll of this condition in the region.
Disease-specific death rates measure the number of deaths directly attributed to alcohol use disorders per 100,000 people, after accounting for age structure. These rates capture both the prevalence of the condition and the likelihood of a fatal outcome once affected. In Europe & Central Asia, variation across countries may reflect differences in disease prevalence, access to treatment, diagnostic capacity, and the presence of comorbidities. Examining trends alongside health expenditure and intervention coverage helps identify where policy action has been most effective.